Klaus Überla to Rituximab
This is a "connection" page, showing publications Klaus Überla has written about Rituximab.
Connection Strength
0.032
-
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity. Eur J Immunol. 2021 10; 51(10):2478-2484.
Score: 0.032